Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00016892
DRKS00016892
Recruiting
Phase 1

Transcutaneous vagus nerve stimulation for prophylaxis of systemic inflammatory response syndrome (SIRS) and treatment of SIRS-associated ileus (NeuroSIRS) - NeuroSIRS

Medizinischen FakultätUniversitätsklinikum Bonn0 sites30 target enrollmentJuly 9, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealthy subjects

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Healthy subjects
Sponsor
Medizinischen FakultätUniversitätsklinikum Bonn
Enrollment
30
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 9, 2020
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Medizinischen FakultätUniversitätsklinikum Bonn

Eligibility Criteria

Inclusion Criteria

  • •Signed consent form
  • •\- Age \> 18 years and \< 45 years
  • •\- male gender
  • •\- Caucasian origin.

Exclusion Criteria

  • •\- known predisposition to constipation or diarrhea
  • •\- surgery or trauma associated with increased blood loss or transfusion of erythrocyte concentrates
  • •\- Blood donation in the last four weeks
  • •\- taking an immunosuppressive or immunomodulatory medication in the last six months
  • •\- Regular medication intake
  • •\- Anamnestically known or indications for cardiovascular pre\-existing conditions
  • •\- vasovagal or orthostatic syncope in the last 12 months
  • •\- resting pulse \< 50/min or \> 100/min
  • •\- Blood pressure systolic \> 150 mmHg or \< 100 mmHg
  • •\- Electrocardiographically proven or anamnestically known cardiac arrhythmias (except 1st\-degree AV block)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Transcutaneous Vagus Nerve Stimulation for the treatment of chronic migraineG43.3Complicated migraine
DRKS00003681cerbomed GmbH46
Recruiting
Not Applicable
Transcutaneous Vagal Nerve Stimulation for the Treatment ofPersistent Atrial Fibrillation (VAST-AF): a Randomized, Controlled,Blinded, Monocentric, Clinical TrialI48.1Persistent atrial fibrillation
DRKS00031382Marienhaus Klinikum Hetzelstift120
Not yet recruiting
Phase 2
Transcutaneous vagus nerve stimulation to enhance exposure efficacy in public speaking anxiety
NL-OMON49420niversiteit Leiden52
Not yet recruiting
Not Applicable
Transcutaneous vagus nerve stimulation to enhance exposure efficacy in public speaking anxiety
NL-OMON20935eiden University Behandel en Expertise Centrum52
Not yet recruiting
Not Applicable
oninvasive vagal nerve stimulation for abdominal symptoms in people with spinal cord injuryAbdominal painspinal cord injuryOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonMusculoskeletal - Other muscular and skeletal disordersPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitationNeurological - Other neurological disordersInjuries and Accidents - Other injuries and accidents
ACTRN12624000010594Royal North Shore Hospital15